Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Yamada S, Fujii T, Yokoyama Y, Kawashima H, Maeda O, Suzuki K, Okada T, Ono E, Yamaguchi J, Takano N, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Kodera Y. Yamada S, et al. Among authors: kawashima h. Cancer Chemother Pharmacol. 2018 May;81(5):815-821. doi: 10.1007/s00280-018-3554-3. Epub 2018 Mar 3. Cancer Chemother Pharmacol. 2018. PMID: 29502139 Clinical Trial.
Feasibility and usefulness of endoscopic ultrasonography-guided shear-wave measurement for assessment of autoimmune pancreatitis activity: a prospective exploratory study.
Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Tanaka H, Sakai D, Ishizu Y, Kuzuya T, Nakamura M, Honda T. Ohno E, et al. Among authors: kawashima h. J Med Ultrason (2001). 2019 Oct;46(4):425-433. doi: 10.1007/s10396-019-00944-4. Epub 2019 Apr 16. J Med Ultrason (2001). 2019. PMID: 30993580 Free PMC article.
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.
Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y. Takano N, et al. Among authors: kawashima h. Nagoya J Med Sci. 2019 May;81(2):233-239. doi: 10.18999/nagjms.81.2.233. Nagoya J Med Sci. 2019. PMID: 31239592 Free PMC article. Clinical Trial.
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies.
Mizuno K, Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Kawashima H, Inukai Y, Toyoda H, Yokota K, Hase T, Maeda O, Kiyoi H, Nagino M, Hibi H, Kodera Y, Fujimoto Y, Sone M, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Fujishiro M. Mizuno K, et al. Among authors: kawashima h. J Gastroenterol. 2020 Jun;55(6):653-661. doi: 10.1007/s00535-020-01677-9. Epub 2020 Mar 2. J Gastroenterol. 2020. PMID: 32124082
Endoscopic Activity and Serum TNF-α Level at Baseline Are Associated With Clinical Response to Ustekinumab in Crohn's Disease Patients.
Murate K, Maeda K, Nakamura M, Sugiyama D, Wada H, Yamamura T, Sawada T, Mizutani Y, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Miyahara R, Ishigami M, Nishikawa H, Fujishiro M. Murate K, et al. Among authors: kawashima h. Inflamm Bowel Dis. 2020 Oct 23;26(11):1669-1681. doi: 10.1093/ibd/izaa086. Inflamm Bowel Dis. 2020. PMID: 32405651
Filtrated Adipose Tissue-Derived Mesenchymal Stem Cell Lysate Ameliorates Experimental Acute Colitis in Mice.
Nishikawa T, Maeda K, Nakamura M, Yamamura T, Sawada T, Mizutani Y, Ito T, Ishikawa T, Furukawa K, Ohno E, Miyahara R, Kawashima H, Honda T, Ishigami M, Yamamoto T, Matsumoto S, Hotta Y, Fujishiro M. Nishikawa T, et al. Among authors: kawashima h. Dig Dis Sci. 2021 Apr;66(4):1034-1044. doi: 10.1007/s10620-020-06359-3. Epub 2020 Jun 1. Dig Dis Sci. 2021. PMID: 32488819
2,070 results